Literature DB >> 10627553

The EICP22 protein of equine herpesvirus 1 physically interacts with the immediate-early protein and with itself to form dimers and higher-order complexes.

W A Derbigny1, S K Kim, G B Caughman, D J O'Callaghan.   

Abstract

The EICP22 protein (EICP22P) of Equine herpesvirus 1 (EHV-1) is an early protein that functions synergistically with other EHV-1 regulatory proteins to transactivate the expression of early and late viral genes. We have previously identified EICP22P as an accessory regulatory protein that has the ability to enhance the transactivating properties and the sequence-specific DNA-binding activity of the EHV-1 immediate-early protein (IEP). In the present study, we identify EICP22P as a self-associating protein able to form dimers and higher-order complexes during infection. Studies with the yeast two-hybrid system also indicate that physical interactions occur between EICP22P and IEP and that EICP22P self-aggregates. Results from in vitro and in vivo coimmunoprecipitation experiments and glutathione S-transferase (GST) pull-down studies confirmed a direct protein-protein interaction between EICP22P and IEP as well as self-interactions of EICP22P. Analyses of infected cells by laser-scanning confocal microscopy with antibodies specific for IEP and EICP22P revealed that these viral regulatory proteins colocalize in the nucleus at early times postinfection and form aggregates of dense nuclear structures within the nucleoplasm. Mutational analyses with a battery of EICP22P deletion mutants in both yeast two-hybrid and GST pull-down experiments implicated amino acids between positions 124 and 143 as the critical domain mediating the EICP22P self-interactions. Additional in vitro protein-binding assays with a library of GST-EICP22P deletion mutants identified amino acids mapping within region 2 (amino acids [aa] 65 to 196) and region 3 (aa 197 to 268) of EICP22P as residues that mediate its interaction with IEP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10627553      PMCID: PMC111477          DOI: 10.1128/jvi.74.3.1425-1435.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

Review 1.  High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function.

Authors:  M Bustin; R Reeves
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1996

2.  Association of herpes simplex virus regulatory protein ICP22 with transcriptional complexes containing EAP, ICP4, RNA polymerase II, and viral DNA requires posttranslational modification by the U(L)13 proteinkinase.

Authors:  R Leopardi; P L Ward; W O Ogle; B Roizman
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

3.  Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1.

Authors:  D J McGeoch; A Dolan; S Donald; F J Rixon
Journal:  J Mol Biol       Date:  1985-01-05       Impact factor: 5.469

4.  The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats.

Authors:  B K Felber; H Paskalis; C Kleinman-Ewing; F Wong-Staal; G N Pavlakis
Journal:  Science       Date:  1985-08-16       Impact factor: 47.728

5.  Activation of transcription by PU.1 requires both acidic and glutamine domains.

Authors:  M J Klemsz; R A Maki
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

6.  A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth.

Authors:  L E Post; B Roizman
Journal:  Cell       Date:  1981-07       Impact factor: 41.582

7.  Chemical probes of extended biological structures: synthesis and properties of the cleavable protein cross-linking reagent [35S]dithiobis(succinimidyl propionate).

Authors:  A J Lomant; G Fairbanks
Journal:  J Mol Biol       Date:  1976-06-14       Impact factor: 5.469

8.  Oncogenic transformation by by equine herpesviruses. II. Coestablishment of persistent infection and oncogenic transformation of hamster embryo cells by equine herpesvirus type 1 preparations enriched for defective interfering particles.

Authors:  R A Robinson; R B Vance; D J O'Callaghan
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

9.  Herpes simplex virus 1 mutant deleted in the alpha 22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in mice.

Authors:  A E Sears; I W Halliburton; B Meignier; S Silver; B Roizman
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

10.  Equine herpesvirus type 1 infected cell polypeptides: evidence for immediate early/early/late regulation of viral gene expression.

Authors:  G B Caughman; J Staczek; D J O'Callaghan
Journal:  Virology       Date:  1985-08       Impact factor: 3.616

View more
  11 in total

1.  Mapping the sequences that mediate interaction of the equine herpesvirus 1 immediate-early protein and human TFIIB.

Authors:  H K Jang; R A Albrecht; K A Buczynski; S K Kim; W A Derbigny; D J O'Callaghan
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

2.  Biological and genotypic properties of defective interfering particles of equine herpesvirus 1 that mediate persistent infection.

Authors:  Paul D Ebner; Seong K Kim; Dennis J O'Callaghan
Journal:  Virology       Date:  2008-09-20       Impact factor: 3.616

3.  Genetic complexity of EHV-1 defective interfering particles and identification of novel IR4/UL5 hybrid proteins produced during persistent infection.

Authors:  Paul D Ebner; Dennis J O'Callaghan
Journal:  Virus Genes       Date:  2006-06       Impact factor: 2.332

4.  The unique IR2 protein of equine herpesvirus 1 negatively regulates viral gene expression.

Authors:  Seong K Kim; Byung C Ahn; Randy A Albrecht; Dennis J O'Callaghan
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

5.  The common equine class I molecule Eqca-1*00101 (ELA-A3.1) is characterized by narrow peptide binding and T cell epitope repertoires.

Authors:  Tobias Bergmann; Carrie Moore; John Sidney; Donald Miller; Rebecca Tallmadge; Rebecca M Harman; Carla Oseroff; Amanda Wriston; Jeffrey Shabanowitz; Donald F Hunt; Nikolaus Osterrieder; Bjoern Peters; Douglas F Antczak; Alessandro Sette
Journal:  Immunogenetics       Date:  2015-09-23       Impact factor: 2.846

6.  The equine herpesvirus-1 IR3 gene that lies antisense to the sole immediate-early (IE) gene is trans-activated by the IE protein, and is poorly expressed to a protein.

Authors:  Byung Chul Ahn; Jonathan E Breitenbach; Seong K Kim; Dennis J O'Callaghan
Journal:  Virology       Date:  2007-02-15       Impact factor: 3.616

7.  The immediate-early 63 protein of Varicella-Zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo.

Authors:  Armin Baiker; Christoph Bagowski; Hideki Ito; Marvin Sommer; Leigh Zerboni; Klaus Fabel; John Hay; William Ruyechan; Ann M Arvin
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

8.  A negative regulatory element (base pairs -204 to -177) of the EICP0 promoter of equine herpesvirus 1 abolishes the EICP0 protein's trans-activation of its own promoter.

Authors:  Seong K Kim; Randy A Albrecht; Dennis J O'Callaghan
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

9.  Interaction of the equine herpesvirus 1 EICP0 protein with the immediate-early (IE) protein, TFIIB, and TBP may mediate the antagonism between the IE and EICP0 proteins.

Authors:  Seong K Kim; Hyung K Jang; Randy A Albrecht; Wilbert A Derbigny; Yunfei Zhang; Dennis J O'Callaghan
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  The IR4 auxiliary regulatory protein expands the in vitro host range of equine herpesvirus 1 and is essential for pathogenesis in the murine model.

Authors:  Jonathan E Breitenbach; Paul D Ebner; Dennis J O'Callaghan
Journal:  Virology       Date:  2008-11-13       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.